Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
Astena Holdings Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥473.00 |
52 Week High | JP¥576.00 |
52 Week Low | JP¥417.00 |
Beta | 0.045 |
11 Month Change | -12.08% |
3 Month Change | -4.06% |
1 Year Change | 7.50% |
33 Year Change | -15.99% |
5 Year Change | 1.28% |
Change since IPO | -7.07% |
Recent News & Updates
Shareholder Returns
8095 | JP Pharmaceuticals | JP Market | |
---|---|---|---|
7D | -13.5% | -7.1% | -11.1% |
1Y | 7.5% | 8.5% | 4.7% |
Return vs Industry: 8095 exceeded the JP Pharmaceuticals industry which returned 4.2% over the past year.
Return vs Market: 8095 exceeded the JP Market which returned -3.7% over the past year.
Price Volatility
8095 volatility | |
---|---|
8095 Average Weekly Movement | 7.1% |
Pharmaceuticals Industry Average Movement | 5.2% |
Market Average Movement | 6.1% |
10% most volatile stocks in JP Market | 9.7% |
10% least volatile stocks in JP Market | 3.2% |
Stable Share Price: 8095 has not had significant price volatility in the past 3 months.
Volatility Over Time: 8095's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1914 | 1,404 | Satoshi Setoguchi | www.astena-hd.com |
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company’s Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas. Its Medical division manufactures and sells semi-solid products, such as ointments, creams, and lotions, as well as solid products such as tablets and powders for the generic drug market; and manufactures a range of dosage forms, including injectable, solid, semi-solid, and liquid dosage forms on contract.
Astena Holdings Co., Ltd. Fundamentals Summary
8095 fundamental statistics | |
---|---|
Market cap | JP¥19.04b |
Earnings (TTM) | JP¥2.09b |
Revenue (TTM) | JP¥53.22b |
9.1x
P/E Ratio0.4x
P/S RatioIs 8095 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
8095 income statement (TTM) | |
---|---|
Revenue | JP¥53.22b |
Cost of Revenue | JP¥35.56b |
Gross Profit | JP¥17.66b |
Other Expenses | JP¥15.57b |
Earnings | JP¥2.09b |
Last Reported Earnings
May 31, 2024
Next Earnings Date
Oct 11, 2024
Earnings per share (EPS) | 51.99 |
Gross Margin | 33.18% |
Net Profit Margin | 3.93% |
Debt/Equity Ratio | 52.5% |
How did 8095 perform over the long term?
See historical performance and comparisonDividends
3.8%
Current Dividend Yield17%
Payout RatioDoes 8095 pay a reliable dividends?
See 8095 dividend history and benchmarksAstena Holdings dividend dates | |
---|---|
Ex Dividend Date | Nov 28 2024 |
Dividend Pay Date | Feb 28 2025 |
Days until Ex dividend | 113 days |
Days until Dividend pay date | 205 days |
Does 8095 pay a reliable dividends?
See 8095 dividend history and benchmarks